The Career Development Program (CDP) is a critical and integral component of the Duke SPORE in Brain Cancer that facilitates the identification, support, and mentoring of promising new and early-stage investigators in translational neuro-oncology. Projects will be encouraged to be broadly collaborative and to test novel paradigms that will further expand the scope of the brain tumor diagnosis, prevention, and management. The DRP will specifically target projects having a strong likelihood of becoming successful and independent research projects or having a high potential of developing into full SPORE projects that replace projects within the SPORE that are not progressing satisfactorily.
The Specific Aims of the CDP are to: 1) Identify and support meritorious translational projects led by NIH-designated new or early stage investigators that have a high probability of impacting the diagnosis, treatment or prevention of brain tumors; 2) Recruit and retain promising women and minority new and early-stage investigators with a career focus in translational neuro-oncology research; 3) Facilitate access to programs for leadership training and a highly successful program for grant writing that includes mentoring of early-stage and new investigators to enable such faculty members to achieve independent faculty status with emphasis on neuro-oncology research; and 4) Provide continuing evaluation of progress on funded projects and facilitate their evolution into full SPORE projects or independently funded projects. This application builds upon the highly successful CDP of the previous Duke Brain Cancer SPORE that resulted in the successful development of several early-stage scientists, including a number of women and minority investigators. This application builds upon and extends this success through the integration of the SPORE CDP with a highly advanced faculty development program, which offers a wide range of short courses to enable young faculty to learn skills related to leadership, scientific writing, personnel management, grants management and others. This integration of the CDP with the Office of Faculty Development will ensure longitudinal mentorship and development of CDP award recipients throughout their tenure at our medical center. We anticipate the successful recruitment of outstanding new talent to the field of neuro-oncology research, as we have done in the past, through this highly visible awards program.

Public Health Relevance

The Career Development Program is of high relevance to the Duke SPORE in Brain Cancer. It is a critical component of our SPORE effort and meets the NIH requirement for all SPOREs. It will take maximum advantage of new research opportunities in brain tumors, attract new outstanding investigators and collaborators to the field of neuro-oncology and, importantly, serve as a source of new translational projects for the SPORE. The CDP will be maintained for the full five years of the SPORE and funded at $50,000 per year by the SPORE with an additional $100,000 per year matching funds provided by the Duke Cancer Institute and Duke School of Medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA190991-03
Application #
9124857
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Gromeier, Matthias; Nair, Smita K (2018) Recombinant Poliovirus for Cancer Immunotherapy. Annu Rev Med 69:289-299
Lin, Jiaxing; Gresham, Jeremy; Wang, Tongrong et al. (2018) bcSeq: an R package for fast sequence mapping in high-throughput shRNA and CRISPR screens. Bioinformatics 34:3581-3583
Swartz, Adam M; Reap, Elizabeth; Norberg, Pamela et al. (2018) A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis. J Immunol Methods 459:90-93
Chong, Mengyang; Yin, Tao; Chen, Rui et al. (2018) CD36 initiates the secretory phenotype during the establishment of cellular senescence. EMBO Rep 19:
Thompson, Eric M; Brown, Michael; Dobrikova, Elena et al. (2018) Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma. J Neuropathol Exp Neurol 77:696-702
Woroniecka, Karolina; Chongsathidkiet, Pakawat; Rhodin, Kristen et al. (2018) T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Clin Cancer Res 24:4175-4186
Woroniecka, Karolina I; Rhodin, Kristen E; Chongsathidkiet, Pakawat et al. (2018) T-cell Dysfunction in Glioblastoma: Applying a New Framework. Clin Cancer Res 24:3792-3802
Zhao, Lintao; He, Ran; Long, Haixia et al. (2018) Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells. Nat Med 24:1536-1544
Cornetta, Kenneth; Duffy, Lisa; Feldman, Steven A et al. (2018) Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience. Mol Ther Methods Clin Dev 10:371-378
Atik, Ahmet F; Suryadevara, Carter M; Schweller, Ryan M et al. (2018) Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells. J Clin Neurosci 56:163-168

Showing the most recent 10 out of 39 publications